Le Lézard
Classified in: Health
Subjects: POL, AVO

National Council for Behavioral Health Members Head to The Hill to Preserve Vital Mental Health and Addiction Bill Before it Expires


WASHINGTON, March 10, 2020 /PRNewswire/ -- Behavioral health care professionals from across the country will come together on Capitol Hill this week to urge members of Congress to support the bipartisan Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/H.R. 1767), which looks to extend and expand Certified Community Behavioral Health Clinics (CCBHCs) for two years and add 11 states before the demonstration expires on May 22.

More than 100 CCBHC advocates will join Sens. Debbie Stabenow (D-Mich.) and Roy Blunt (R-Mo.) at a March 11 event to outline the benefits the clinics provide to tens of thousands of vulnerable Americans with mental health or addictions and call for immediate action by lawmakers.

"Neglecting to extend and expand the CCBHC program would devastate our nation. These clinics play such a vital role in mental health and addictions care to the most vulnerable people in our communities," National Council for Behavioral Health President and CEO Chuck Ingoglia said. "We are grateful for the work of Sens. Stabenow and Blunt and many others who want to bring the benefits of CCBHCs to more people in more states and communities while allowing those currently served by a CCBHC to continue receiving the treatment they depend on through the Excellence in Mental Health and Addiction Treatment Expansion Act."

In 21 states, CCBHCs have delivered treatment to more than 400,000 patients, according to the Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA). Since CCBHCs began their systems transformation two years ago, they have been filling the gap in the unmet need for addiction and mental health care, supporting local criminal justice systems by providing effective diversion and reentry solutions and increasing access to evidence-based mental health and addiction treatment across the country.

"It is time to act. Mental illness and drug addictions affect about one in five people in our country. It is exciting to see the tremendous success of these community clinics in delivering treatment and changing the lives of hundreds of thousands of people. The results certainly make the case for expanding these highly successful services to people in communities across our country," said Sen. Stabenow.

Today, the National Council released a new report, "Hope for the Future: CCBHCs Expanding Mental Health and Addiction Treatment," outlining the early impact of CCHBCs as they change the way mental health and addiction treatment services are provided.

The report highlights:

The National Council is committed to establishing a total of 500 CCBHCs nationwide, serving 2.9 million individuals, by 2025.

"Nearly one in five Americans suffers from a mental or behavioral health issue that is diagnosable and almost always treatable, but only a fraction receives the care they need," said Sen. Blunt. "The National Council's new report shows that the Excellence in Mental Health Act has had a substantial impact in bridging the gap and improving access to care. As one of the pilot states participating in the Excellence program, CCBHCs in Missouri have helped people get treatment faster and closer to home, provided new tools to law enforcement and brought us closer to our goal of treating mental and behavioral health like all other health. Given the demonstrated success of the Excellence program so far, now is the time to keep building on the progress that's been made by extending and expanding funding for CCBHCs."

At the March 11 fly-in event, Sens. Stabenow and Blunt will voice their support for extending and expanding CCBHCs. Other speakers include:

Press Conference Details:
CCBHC Advocacy Event
Wednesday, March 11
11:30 a.m. - 12:30 p.m.
325 Russell Senate Office Building
Kennedy Caucus Room

CCBHC Quick Facts:

Note to Reporters/Editors: Press conference will be held following remarks from speakers. All speakers will be available for questions. Live stream the event here.

About the National Council for Behavioral Health
The National Council for Behavioral Health is the unifying voice of America's health care organizations that deliver mental health and addictions treatment and services. Together with our 3,326 member organizations serving over 10 million adults, children and families living with mental illnesses and addictions, the National Council is committed to all Americans having access to comprehensive, high-quality care that affords every opportunity for recovery. The National Council introduced Mental Health First Aid USA and more than 2 million Americans have been trained.

Contact:
Sophia Majlessi
[email protected]
(202) 621-1631

SOURCE National Council for Behavioral Health


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: